logo

Slide Shows

Share
Events

Biotech Stocks Facing FDA Decision In March After a banner year in 2018, the novel drug approval is off to an uncharacteristically slow start this year. No novel drug was approved in January and three were approved in February.

Some more of the best products at CES 2019 The Consumer Electronics Show or CES at the World Trade Center Las Vegas is seen as a global stage for displaying the latest products and technologies in consumer electronics. It is the platform where next-generation innovations are introduced to the marketplace and thus, attracts a lot of attention from the world’s media. CES is organized by the Consumer Technology Association or CTA, the trade association representing the $398 billion U.S. consumer technology industry. The first CES was held in June 1967 in New York City. Over the years, CES has grown to become one of the most influential technology events in the world.

Some of the best products at CES 2019 The Consumer Electronics Show or CES at the World Trade Center Las Vegas is seen as a global stage for displaying the latest products and technologies in consumer electronics. It is the platform where next-generation innovations are introduced to the marketplace and thus, attracts a lot of attention from the world’s media. CES is organized by the Consumer Technology Association or CTA, the trade association representing the $398 billion U.S. consumer technology industry. The first CES was held in June 1967 in New York City. Over the years, CES has grown to become one of the most influential technology events in the world.

Biotech Stocks Facing FDA Decision In February 2018 was a banner year not just for novel drug approvals but for novel device approvals as well. Last year, 59 novel drugs and 106 novel devices were greenlighted by the regulatory agency compared to 46 novel drugs and 99 novel devices approved in 2017. Now, let's take a look at the biotech stocks that await a ruling from the FDA in February 2019.